1800 202 8726
Pancreatic Cancer Imaging

PET-CT for Pancreatic Cancer — What It Adds — and Where It Falls Short

A contrast CT gives your team the picture they need to stage pancreatic cancer and plan surgery. PET-CT is added in specific situations — not as a routine step, and not as a replacement. Understanding what it can and cannot show helps you ask better questions at your next appointment.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

  • CT is the primary test — Contrast CT shows vascular involvement and guides surgical planning — PET-CT cannot replace this assessment.
  • PET adds a functional layer — It looks for metabolically active deposits that appear normal or ambiguous on CT, most often before surgery.
  • It has real blind spots — Peritoneal spread, small lesions, and low-metabolic tumour types are frequently missed on PET.
  • Not every patient needs both — Your oncologist will explain the reason PET is being added if it is ordered for you.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A contrast-enhanced CT scan remains the primary test for staging pancreatic cancer and deciding whether surgery is possible. PET-CT is used in addition when your team wants to look for hidden distant spread. It does not replace CT and cannot assess how close the tumour is to blood vessels — that is CT's job.

CION offers PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city, with no hidden charges. Indicative price, as of September 2026.

Is a CT scan enough to stage pancreatic cancer?

A contrast-enhanced CT scan — sometimes called a pancreatic protocol CT — is the test your surgical and oncology team uses to stage pancreatic cancer. It shows the tumour's size, its position relative to major blood vessels, and whether cancer has spread to the liver or nearby lymph nodes.

This vascular picture is what matters most when deciding whether surgery is possible. PET-CT cannot replace this assessment. It does not show blood vessel involvement clearly enough to make that decision, and for most patients with a good quality CT, adding PET does not change the surgical plan.

If your CT gives a clear picture of your disease, PET-CT may not be ordered at all.

When does your team order a PET-CT scan?

PET-CT is ordered when your team wants to look for deposits of cancer that CT has not clearly shown — particularly small clusters in distant lymph nodes, the liver, or other organs. Finding even one hidden metastasis before an operation can change the decision to proceed with surgery.

NCCN guidelines recognise PET-CT as a reasonable option before surgery in pancreatic cancer, used alongside — not instead of — contrast CT. It is also used after treatment when CT findings are difficult to interpret because of changes in the tissue caused by the treatment itself.

Not every centre or every situation calls for it. Your oncologist will explain the reason it is being added if it is ordered for you.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

Did you know?

Peritoneal carcinomatosis — cancer spreading to the lining of the abdomen — is one of the most common patterns of spread in pancreatic cancer. PET-CT regularly fails to detect it, which is why some surgical teams use diagnostic laparoscopy alongside imaging before committing to a major operation.

Source: NCCN Guidelines: Pancreatic Adenocarcinoma

What does PET-CT not show well in pancreatic cancer?

Can PET-CT show whether the tumour can be surgically removed?

No. The decision about whether a tumour is resectable depends on how close it sits to the major blood vessels around the pancreas — the portal vein, the superior mesenteric artery, and others. Contrast CT shows this in much finer detail than PET-CT. This is why CT remains the primary staging tool for surgical planning, and PET is not used to make or override a resectability decision.

Does PET-CT reliably detect spread to the peritoneum?

Not reliably. Cancer that has seeded the lining of the abdomen tends to form small, flat deposits with low metabolic activity. These frequently do not show significant uptake on PET. Peritoneal spread is a common pattern in pancreatic cancer, and its absence on PET does not mean it is absent. This is one of the reasons some surgical teams add diagnostic laparoscopy before a planned resection.

Are there tumour types where PET gives less reliable results?

Yes. Well-differentiated and mucinous tumours tend to have lower metabolic activity, which means they take up less of the radiotracer used in PET imaging. This can produce a falsely reassuring result — the scan looks clear, but disease may still be present. Your oncologist will take the tumour's characteristics into account when deciding how much weight to give a PET result and whether additional tests are needed.

Can pancreatitis cause a false positive on PET-CT?

Yes. Active inflammation in the pancreas — including autoimmune pancreatitis — can show uptake on PET that resembles a malignant tumour. This is one of the more common causes of a misleading result in this region. It is why PET findings are never read in isolation: they are always interpreted alongside the CT component and the full clinical picture, including symptoms and blood tests.

Does a clear PET scan mean the cancer has not spread?

No. A clear PET does not rule out spread. PET misses peritoneal deposits frequently, tends to miss small lesions, and is less reliable in certain tumour subtypes. A negative result narrows the picture and is a useful piece of information, but it does not guarantee the absence of distant disease. Your team will tell you what the result means in the context of your CT and your full clinical picture.

Book a PET-CT at CION from Rs 10,499 — among the lowest published prices in Hyderabad — with an oncologist-reviewed report and a free Rs 950 consultation, across 4 partner centres. Indicative price, as of September 2026.

Explore 100 more PET-CT for Your Cancer Type topics

All PET-CT for Your Cancer Type →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Will I need both a CT and a PET-CT scan for pancreatic cancer?

Not always. Contrast CT is the primary test and is sufficient in many cases. PET-CT is added when your team believes it will change the plan — most often to look for hidden distant spread before surgery, or when CT findings after treatment are hard to interpret. Whether you need both depends on your stage, your situation, and what the CT has already shown.

What does PET-CT show that CT cannot for pancreatic cancer?

PET-CT shows metabolic activity — where cells are using glucose at an elevated rate, which cancer cells tend to do. This can reveal deposits in distant organs or lymph nodes that appear normal or ambiguous on CT. It adds a functional layer to the anatomical picture CT provides. The two are read together, not separately, and neither alone gives the complete picture.

Can PET-CT tell whether a pancreatic tumour can be removed?

No. Resectability depends on the tumour's relationship to the blood vessels surrounding the pancreas. Contrast CT shows this relationship in detail. PET-CT cannot make this assessment, which is why CT remains the primary tool when a surgical decision needs to be made. PET may add information about distant spread, but the vascular picture is CT's domain.

What happens during a PET-CT scan?

You will be asked not to eat for several hours before the scan. A small amount of radiotracer is injected through a vein, and you then wait roughly an hour while it is absorbed. The scan itself typically takes around 20 to 30 minutes lying in the machine. The tracer clears from your body within hours, and you may be asked to avoid close contact with young children or pregnant women for a short period afterwards.

Does a normal PET-CT mean the cancer has not spread?

Not definitively. PET misses peritoneal spread — one of the most common sites in pancreatic cancer — and frequently misses small deposits and low-metabolic tumour types. A clear result is useful and worth knowing, but your team will interpret it alongside your CT, your tumour markers, and your symptoms before drawing a conclusion. A clear PET is a good sign, not a guarantee.

Is PET-CT available at CION?

CION coordinates PET-CT through partner imaging centres. If your oncologist orders a PET-CT as part of your assessment, the team will arrange the referral and ensure the scan is reviewed alongside your contrast CT before your next appointment.

Call now Book free consultation